For Investors

Investor Relations

Latest Press Releases

All Press Releases
Date Title
January 14, 2022
Novan Announces Presentation of Two Posters at the 2022 Winter Clinical Dermatology Conference
November 12, 2021
Novan to Participate in the Virtual Investor Roundtable Event
November 10, 2021
Novan Provides Corporate Update and Reports Third Quarter 2021 Financial Results
November 9, 2021
Novan Announces Favorable Preclinical Safety Data and Intent to Advance SB019 for Treatment of COVID-19

Recent SEC Filings

All SEC Filings

Upcoming Events

More 
More events are coming soon.

Stock Information

more

Exchange
Volume
Today's Open
Previous Close

Data as of Jan 17, 2022 12:13 PM EST

Data Provided by Refinitiv. Minimum 15 minutes delayed.

June 1, 2021
October 21, 2016

Corporate Governance

Click here to view our Corporate Governance information.

IR & Media Contact

Information Request

Click here to request information.

Presentation

More
December 21, 2021
October 22, 2021

Annual Report

More
April 30, 2021

Analyst Coverage

more
Firm Analyst
Brookline Capital Markets
Kemp Dolliver
Cantor Fitzgerald
Jennifer Kim
HC Wainwright & Co.
Oren Livnat, CFA
Roth Capital Partners
Jonathan Aschoff Ph.D.
Zacks Small-Cap Research
John D. Vandermosten, CFA

Novan, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Novan, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Novan, Inc. or its management. Novan, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Transfer Agent

E-mail Alerts

  • Sign up here to get latest notifications whenever Novan inc. posts new information to the site.